alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-beta-D-Glcp-O(CH2)2S(CH2)2CO2Me

Term ID

CHEBI:63014

Synonyms

2-(2-methoxycarbonylethylthio)ethyl alpha-D-galactopyranosyl-(1->4)-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranoside
alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-O(CH2)2S(CH2)2CO2Me
alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-O-CETE
alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-beta-D-Glcp-O-CETE
Galalpha1-4Galbeta1-4Glcbeta-O-CETE
methyl 3-[(2-{[alpha-D-galactopyranosyl-(1->4)-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranosyl]oxy}ethyl)sulfanyl]propanoate
methyl 3-[(2-{[alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl]oxy}ethyl)sulfanyl]propanoate

Definition

A glycoside that consists of alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucose having a 2-(2-methoxycarbonylethylthio)ethyl (CETE) moiety attached to the reducing end anomeric centre.

References

PMID:2456994
Reaxys:5692077

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-beta-D-Glcp-O(CH2)2S(CH2)2CO2Me

Phenotype where environments contain alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-beta-D-Glcp-O(CH2)2S(CH2)2CO2Me

Phenotype modified by environments containing alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-beta-D-Glcp-O(CH2)2S(CH2)2CO2Me

Human Disease Model